tradingkey.logo

Aclarion Inc

ACON
View Detailed Chart

6.995USD

0.0000.00%
Close 08/01, 16:00ETQuotes delayed by 15 min
4.07MMarket Cap
LossP/E TTM

Aclarion Inc

6.995

0.0000.00%
Intraday
1m
30m
1h
D
W
M
D

Today

-1.78%

5 Days

-6.42%

1 Month

-6.11%

6 Months

-96.10%

Year to Date

-99.46%

1 Year

-99.73%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 1 analysts
BUY
Current Rating
20.000
Target Price
185.92%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

552
Total
5
Median
6
Average
Company name
Ratings
Analysts
Aclarion Inc
ACON
1
CRISPR Therapeutics AG
CRSP
29
Intellia Therapeutics Inc
NTLA
28
Exact Sciences Corp
EXAS
27
Ionis Pharmaceuticals Inc
IONS
27
IQVIA Holdings Inc
IQV
25
1
2
3
...
111

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Strong sell
Sell(11)
Neutral(1)
Buy(0)
Indicators
Sell(5)
Neutral(1)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.013
Sell
RSI(14)
41.359
Neutral
STOCH(KDJ)(9,3,3)
28.737
Sell
ATR(14)
0.410
High Vlolatility
CCI(14)
-199.022
Sell
Williams %R
67.183
Sell
TRIX(12,20)
0.041
Sell
StochRSI(14)
6.172
Oversold
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
7.325
Sell
MA10
7.362
Sell
MA20
7.374
Sell
MA50
7.202
Sell
MA100
9.319
Sell
MA200
512.644
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS), and proprietary biomarkers to optimize clinical treatments. It has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that the Company has demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. It uses a magnet to apply a pulsed magnetic field to a patient, sensors to detect radio waves that emanate from the resonant vibrations of different chemicals in the body in response to that pulsed magnetic field and a computer to create detailed images of tissue structures in the patient based on those detected chemical signals.
Ticker SymbolACON
CompanyAclarion Inc
CEOMr. Brent Ness
Websitehttps://aclarion.com/
KeyAI